GlassScriptPhysician profile
Jennifer L August
NPI 1871628693
$3,232.69
in general payments reported to CMS, 2019-2025
23 companies · $1,528 in 2025
The $1,528 reported for 2025 was more than what 87% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $106 · 2022: $172 · 2023: $420 · 2024: $1,006 · 2025: $1,528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,935 · Long Term Medical Supply Or Device Loan: $19.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,934.51 |
| Long Term Medical Supply Or Device Loan | $19.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $524.80 | 2021-2025 | Evenity, Otezla, Enbrel |
| Novo Nordisk INC | $384.38 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Abbott Laboratories | $378.58 | 2021-2025 | Freestyle Libre 3, Freestyle Insulinx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $228.31 | 2022-2025 | Jardiance, Ofev |
| Lilly USA, LLC | $214.86 | 2021-2025 | Zepbound, Mounjaro, Taltz |
| Glaxosmithkline, LLC. | $195.46 | 2023-2025 | Benlysta |
| Xeris Pharmaceuticals, INC. | $174.22 | 2024-2025 | Gvoke Hypopen, Recorlev |
| E.R. Squibb & Sons, L.L.C. | $160.86 | 2023-2025 | Orencia |
| Insulet Corporation | $150.00 | 2025 | Omnipod |
| Fresenius Kabi USA, LLC | $127.10 | 2023-2025 | Idacio, Tyenne |
| Medtronic, INC. | $124.02 | 2023-2025 | Minimed 780g |
| Tandem Diabetes Care, INC. | $103.08 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ucb, INC. | $98.39 | 2023-2025 | Bimzelx, Cimzia |
| Beta Bionics, INC. | $85.91 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Bayer Healthcare Pharmaceuticals INC. | $55.66 | 2024-2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $51.54 | 2023-2024 | Dexcom G6 Transmitter |
| Abbvie INC. | $34.81 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $29.76 | 2025 | |
| Sequel Med Tech, LLC | $26.00 | 2025 | Twiist |
| Sanofi-Aventis U.S. LLC | $24.73 | 2023 | |
| Genzyme Corporation | $20.37 | 2023 | |
| Boston Scientific Corporation | $19.98 | 2021 | |
| Mallinckrodt Hospital Products INC. | $19.87 | 2025 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer August listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.